These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30040505)

  • 21. External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries.
    Ukah UV; Payne B; Lee T; Magee LA; von Dadelszen P;
    Hypertension; 2017 Apr; 69(4):705-711. PubMed ID: 28167685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of proteinuria in preeclampsia and its predictive role in maternal and neonatal outcomes.
    Tanacan A; Fadiloglu E; Beksac MS
    Hypertens Pregnancy; 2019 May; 38(2):111-118. PubMed ID: 30939965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal complications and perinatal outcomes associated with gestational hypertension and severe preeclampsia in Taiwanese women.
    Liu CM; Cheng PJ; Chang SD
    J Formos Med Assoc; 2008 Feb; 107(2):129-38. PubMed ID: 18285245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microalbuminuria is a predictor of adverse pregnancy outcomes including preeclampsia.
    Jayaballa M; Sood S; Alahakoon I; Padmanabhan S; Cheung NW; Lee V
    Pregnancy Hypertens; 2015 Oct; 5(4):303-7. PubMed ID: 26597745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinuria in preeclampsia: Not essential to diagnosis but related to disease severity and fetal outcomes.
    Dong X; Gou W; Li C; Wu M; Han Z; Li X; Chen Q
    Pregnancy Hypertens; 2017 Apr; 8():60-64. PubMed ID: 28501282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
    Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
    Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Predictors of Preeclampsia in Pregnant Women with Chronic Kidney Disease.
    Sorohan BM; Andronesi A; Ismail G; Jurubita R; Obrisca B; Baston C; Harza M
    Medicina (Kaunas); 2020 Apr; 56(5):. PubMed ID: 32349458
    [No Abstract]   [Full Text] [Related]  

  • 28. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
    Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P
    Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
    Gu W; Lin J; Hou Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoproteinemia as a parameter of poor perinatal/neonatal outcomes in women with preeclampsia diagnosed as hypertension plus proteinuria.
    Morikawa M; Mayama M; Saito Y; Akabane-Nakagawa K; Umazume T; Chiba K; Kawaguchi S; Cho K; Watari H
    Pregnancy Hypertens; 2020 Jul; 21():111-117. PubMed ID: 32492636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can serum HCG values be used in the differential diagnosis of pregnancy complicated by hypertension?
    Gurbuz A; Karateke A; Mengulluoglu M; Gedikbasi A; Ozturkmen M; Kabaca C; Sahinoglu Z
    Hypertens Pregnancy; 2004; 23(1):1-12. PubMed ID: 15117595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia.
    Oztas E; Ozler S; Ersoy AO; Iskender CT; Sucak A; Ergin M; Uygur D; Danisman N
    J Perinat Med; 2016 Apr; 44(3):269-75. PubMed ID: 26352072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.
    von Dadelszen P; Payne B; Li J; Ansermino JM; Broughton Pipkin F; Côté AM; Douglas MJ; Gruslin A; Hutcheon JA; Joseph KS; Kyle PM; Lee T; Loughna P; Menzies JM; Merialdi M; Millman AL; Moore MP; Moutquin JM; Ouellet AB; Smith GN; Walker JJ; Walley KR; Walters BN; Widmer M; Lee SK; Russell JA; Magee LA;
    Lancet; 2011 Jan; 377(9761):219-27. PubMed ID: 21185591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Random urine protein creatinine ratio as a preadmission test in hypertensive pregnancies with urinary protein creatinine ratio.
    Eslamian L; Behnam F; Tehrani ZF; Jamal A; Marsoosi V
    Acta Med Iran; 2011; 49(2):81-4. PubMed ID: 21598214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy outcome in proteinuria-onset and hypertension-onset preeclampsia.
    Sarno L; Maruotti GM; Saccone G; Sirico A; Mazzarelli LL; Martinelli P
    Hypertens Pregnancy; 2015; 34(3):284-90. PubMed ID: 25799185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should the spot albumin-to-creatinine ratio replace the spot protein-to-creatinine ratio as the primary screening tool for proteinuria in pregnancy?
    Cade TJ; de Crespigny PC; Nguyen T; Cade JR; Umstad MP
    Pregnancy Hypertens; 2015 Oct; 5(4):298-302. PubMed ID: 26597744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia.
    Kozic JR; Benton SJ; Hutcheon JA; Payne BA; Magee LA; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Oct; 33(10):995-1004. PubMed ID: 22014776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia?
    Tokmak A; Güney G; Aksoy RT; Guzel AI; Topcu HO; Keçecioğlu TS; Uygur D
    J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1451-6. PubMed ID: 25133554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia.
    Ukah UV; Payne B; Hutcheon JA; Ansermino JM; Ganzevoort W; Thangaratinam S; Magee LA; von Dadelszen P
    Hypertension; 2018 Apr; 71(4):659-665. PubMed ID: 29440330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of adverse maternal and perinatal outcomes in preeclampsia based on B-type natriuretic peptide: a retrospective study.
    Hong H; Zhang L; Hong F; Xiao J; Sun W; Dong L; Li M
    Ann Palliat Med; 2021 Dec; 10(12):12190-12207. PubMed ID: 35016416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.